CClinicalTrials.gg
CompletedNCT02826135Updated Jul 22, 2021

Prediction of Fluid Responsiveness in Children With Single Ventricle

An interventional study of abdominal compression in Hypovolemia, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 3 Months to 5 Years. Per ClinicalTrials.gov, last updated 2021-07-22.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Not applicable
Ages
3 Months to 5 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate predictability of an abdominal compression-induced change of blood pressure for fluid responsiveness in children with single ventricle (bidirectional cavopulmonary shunt and Fontan tract).

Read the detailed description

The purpose of this study is to evaluate predictability of an abdominal compression-induced change of blood pressure for fluid responsiveness in children with single ventricle (bidirectional cavopulmonary shunt and Fontan tract).

When there are clinical signs of hypovolemia, such as hypotension, decreased urine output or decreased central venous pressure, right upper abdomen is gently compressed for 10 seconds. Changes of blood pressure are continuously recorded during this period. About 3 min later, intravenous colloid fluid 10 mL/kg is infused for 20 min.

To evaluate the change of cardiac output, transesophageal or transthoracic echocardiography is performed before and after fluid administration. In addition, hemodynamic parameters including pulse pressure variation, systolic pressure variation, pleth variability index and central venous pressure are also recorded before and after fluid administration.

Finally, patients will be divided into fluid responder group and non-responder group. If cardiac output measured using echocardiography increases over 15% after fluid administration, the patient is fluid responder. Using ROC curve, diagnostic power of abdominal compression-induced blood pressure change for fluid responsiveness will be evaluated

02

Conditions studied

  • Hypovolemia

Browse trials for

03

In context

Hypovolemia

133 studies on the registry are indexed under Hypovolemia; 19 are open to participants now.

This study's enrollment of 64 is above the median of 43 across 66 interventional studies indexed under Hypovolemia.

Browse Hypovolemia studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric patients undergoing elective surgery, who require invasive blood pressure and central venous pressure monitoring during surgery
  • Patients with bidirectional cavopulmonary shunt or fontan tract

Exclusion criteria

Exclusion Criteria:

  • renal, hepatic and pulmonary disease
  • preoperative infection: increased CPR, WBC over 10,000, and with fever
  • genetic and hematologic disease
  • ventricular dysfunction
  • increased intracranial pressure
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    Pediatric patients with hypovolemic state

    Right upper abdominal compression is performed in patients with hypovolemic signs including hypotension, decreased urine output or decreased central venous pressure. Changes of blood pressure during abdominal compression is continuously recorded.

    Procedure: abdominal compression

Interventions

  • Procedureabdominal compression

    When there are clinical signs of hypovolemia, such as hypotension in pediatric patients with single ventricle, decreased urine output or decreased central venous pressure, right upper abdomen is gently compressed for 10 seconds. Changes of blood pressure are continuously recorded during this period. About 3 min later, intravenous colloid fluid 10 mL/kg is infused for 20 min.

06

What researchers measure

Primary outcomes

  1. Changes in stroke volume index after volume expansion

    Time frame: before and after fluid administration (20 min)

Secondary outcomes

  1. Changes in pleth variability index after volume expansion

    Time frame: before and after fluid administration (20 min)

  2. 3.Changes in respiratory changes of peak aortic blood flow velocities after volume expansion

    Time frame: before and after fluid administration (20 min)

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, 110-744, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02826135
Lead sponsor
Seoul National University Hospital
Responsible party
Jin-Tae Kim (Associated professor, Seoul National University Hospital) — Principal investigator
First posted
Jul 7, 2016
Start date
Dec 2, 2016
Primary completion
Jun 20, 2021
Completion
Jun 30, 2021
Last update
Jul 22, 2021

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion